- Home
- NMRA vs USAU Comparison
NMRA vs USAU Comparison
Compare NMRA & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- USAU
- Stock Information
- Founded
- NMRA 2019
- USAU N/A
- Country
- NMRA United States
- USAU United States
- Employees
- NMRA N/A
- USAU N/A
- Industry
- NMRA
- USAU Precious Metals
- Sector
- NMRA
- USAU Basic Materials
- Exchange
- NMRA Nasdaq
- USAU Nasdaq
- Market Cap
- NMRA 121.0M
- USAU 126.8M
- IPO Year
- NMRA 2023
- USAU N/A
- Fundamental
- Price
- NMRA $0.84
- USAU $12.50
- Analyst Decision
- NMRA Buy
- USAU Strong Buy
- Analyst Count
- NMRA 8
- USAU 2
- Target Price
- NMRA $9.29
- USAU $16.50
- AVG Volume (30 Days)
- NMRA 1.4M
- USAU 463.1K
- Earning Date
- NMRA 08-05-2025
- USAU 07-28-2025
- Dividend Yield
- NMRA N/A
- USAU N/A
- EPS Growth
- NMRA N/A
- USAU N/A
- EPS
- NMRA N/A
- USAU N/A
- Revenue
- NMRA N/A
- USAU N/A
- Revenue This Year
- NMRA N/A
- USAU N/A
- Revenue Next Year
- NMRA N/A
- USAU N/A
- P/E Ratio
- NMRA N/A
- USAU N/A
- Revenue Growth
- NMRA N/A
- USAU N/A
- 52 Week Low
- NMRA $0.61
- USAU $4.71
- 52 Week High
- NMRA $17.19
- USAU $14.39
- Technical
- Relative Strength Index (RSI)
- NMRA 52.19
- USAU 53.84
- Support Level
- NMRA $0.72
- USAU $11.91
- Resistance Level
- NMRA $0.85
- USAU $13.20
- Average True Range (ATR)
- NMRA 0.07
- USAU 0.72
- MACD
- NMRA -0.01
- USAU -0.09
- Stochastic Oscillator
- NMRA 62.35
- USAU 42.91
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.